Literature DB >> 26063202

China upgrades surveillance and control measures of Middle East respiratory syndrome (MERS).

Jianjun Gao1, Peipei Song.   

Abstract

Three years after the identification of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia, the first case of MERS in China was reported on May 29, 2015. Although the Chinese government issued the MERS Prevention and Control Plan in 2013, a novel edition was released on June 5, 2015 to better cope with the current epidemic situation. The revised Plan refines the descriptions in case-finding and establishment of case-monitoring systems. In addition, tougher regulations on close contacts of confirmed patients and suspected cases are introduced in this new Plan. It is expected these countermeasures will play a greater role in surveilling and controlling MERS in China.

Entities:  

Mesh:

Year:  2015        PMID: 26063202     DOI: 10.5582/bst.2015.01082

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  4 in total

1.  Predictors of human-infective RNA virus discovery in the United States, China, and Africa, an ecological study.

Authors:  Feifei Zhang; Margo Chase-Topping; Chuan-Guo Guo; Mark E J Woolhouse
Journal:  Elife       Date:  2022-06-06       Impact factor: 8.713

2.  Middle East Respiratory Syndrome and Medical Students: Letter from China.

Authors:  Mengxue Liu; Chengsheng Jiang; Connor Donovan; Yufeng Wen; Wenjie Sun; Sun Wenjie
Journal:  Int J Environ Res Public Health       Date:  2015-10-23       Impact factor: 3.390

3.  MERS may not be SARS; but India is still vulnerable.

Authors:  Lalit Kant
Journal:  Indian J Med Res       Date:  2015-08       Impact factor: 2.375

4.  Serological Study of An Imported Case of Middle East Respiratory Syndrome and His Close Contacts in China, 2015.

Authors:  Wen Ling Wang; Hui Juan Wang; Yao Deng; Tie Song; Jia Ming Lan; Gui Zhen Wu; Chang Wen Ke; Wen Jie Tan
Journal:  Biomed Environ Sci       Date:  2016-03       Impact factor: 3.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.